Email Alert RSS
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2024  > 
WU Jiajing, LI Yan, LIANG Yuxia, HUA Huijuan, ZHAO Bo. Mechanism of Fibroblast Growth Factor in Alzheimer's Disease[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0641
Citation: WU Jiajing, LI Yan, LIANG Yuxia, HUA Huijuan, ZHAO Bo. Mechanism of Fibroblast Growth Factor in Alzheimer's Disease[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0641
shu

Mechanism of Fibroblast Growth Factor in Alzheimer's Disease

doi: 10.12290/xhyxzz.2023-0641

  • 1 The First Clinical Medical College of Gansu University of Traditional Chinese Medicine, Lanzhou 730030, China;

  • 2 Department of Neurology, The 940 th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China

Funds:

Postgraduate Tutor Special Project of The 940th Hospital of Joint Logistics Support force of Chinese People’s Liberation Army (2022yxky012,2023yxky008）

  • Received Date: 2023-12-19
  • Accepted Date: 2024-03-01
    • Available Online: 2024-04-24
    Abstract
  • Alzheimer's disease(AD) is the most common neurodegenerative disease, has shown a trend of younger, most patients once onset, cognitive function will show a progressive decline, to the society and the family brings a heavy burden. Studies have shown that fibroblast growth factor (FGF) can be involved in the pathogenesis of AD through multiple mechanisms.In recent years, the research of FGF in AD animal models has made a breakthrough. This article reviews the mechanism of FGF in AD, providing new ideas for elucidating the pathogenesis and early diagnosis of AD.
    • FullText(HTML)
  • loading
    • References(53)
  • [1] 2023 Alzheimer's disease facts and figures. Alzheimers Dement. 2023. 19(4):1598-1695.
    [2] Ranasinghe KG, Petersen C, Kudo K, et al. Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease. Alzheimers Dement. 2021. 17(12):2009-2019.
    [3] Moonen S, Koper MJ, Van Schoor E, et al. Pyroptosis in Alzheimer's disease:cell type-specific activation in microglia, astrocytes and neurons[J]. Acta Neuropathol, 2023,145(2):175-195.
    [4] Xian YF, Qu C, Liu Y, et al. Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease. Oxid Med Cell Longev. 2020. 2020:5920476.
    [5] Xie Y, Su N, Yang J, et al. FGF/FGFR signaling in health and disease[J]. Signal Transduct Target Ther, 2020,5(1):181.
    [6] Sacco A, Federico C, Giacomini A, et al. Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88. Blood. 2021. 137(18):2495-2508.
    [7] Lathe R, St Clair D. Programmed ageing:decline of stem cell renewal, immunosenescence, and Alzheimer's disease. Biol Rev Camb Philos Soc. 2023.
    [8] Lottini G, Plicanti E, Lai M, Quaranta P, Pistello M, Freer G. Canonical fibroblast growth factors in viral infection. Rev Med Virol. 2023:e2452.
    [9] Klimaschewski L, Claus P. Fibroblast Growth Factor Signalling in the Diseased Nervous System. Mol Neurobiol. 2021. 58(8):3884-3902.
    [10] Bayle A, Martin-Romano P, Loriot Y. FIGHT against FGF/FGFR alterations:what are the next steps. Ann Oncol. 2022. 33(5):460-462.
    [11] J., Schlessinger. Receptor Tyrosine Kinases:Legacy of the First Two Decades. Cold Spring Harbor Perspectives in Biology. 2014.
    [12] Giacomini A, Grillo E, Rezzola S, et al. The FGF/FGFR system in the physiopathology of the prostate gland. Physiol Rev. 2021. 101(2):569-610.
    [13] Liu Y, Yu F, Zhang B, et al. Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides. Asian J Pharm Sci. 2019. 14(5):511-520.
    [14] Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005. 16(2):233-47.
    [15] Dhlamini Q, Wang W, Feng G, et al. FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress[J]. Mol Med, 2022,28(1):73.
    [16] Park HB, Baek KH. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers[J]. Biochim Biophys Acta Rev Cancer, 2022,1877(3):188736.
    [17] Zhang B, Zhao J, Wang Z, Xu L, Liu A, Du G. DL0410 attenuates oxidative stress and neuroinflammation via BDNF/TrkB/ERK/CREB and Nrf2/HO-1 activation. Int Immunopharmacol. 2020. 86:106729.
    [18] Zhan-Qiang H, Hai-Hua Q, Chi Z, et al. miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling[J]. Neurologia (Engl Ed), 2021
    [19] Luo Q, Schnöder L, Hao W, et al. p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer's disease mice[J]. Aging Cell, 2022,21(8):e13679.
    [20] Fakhri S, Iranpanah A, Gravandi MM, et al. Natural products attenuate PI3K/Akt/mTOR signaling pathway:A promising strategy in regulating neurodegeneration[J]. Phytomedicine, 2021,91:153664.
    [21] Peng X, Guo H, Zhang X, et al. TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro[J]. Mol Neurobiol, 2023,60(5):2470-2485.
    [22] Wang S, Sudan R, Peng V, et al. TREM2 drives microglia response to amyloid-β via SYK-dependent and-independent pathways. Cell. 2022. 185(22):4153-4169.e19.
    [23] Singh N, Das B, Zhou J, et al. Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance[J]. Sci Adv, 2022,8(29):eabo3610.
    [24] Wang GQ, Zhou P, Xie DJ, et al.[Effects of Huangpu Tongqiao Capsules on EGFR-PLCγ signal pathway of hippocampus in rats with Alzheimer's disease]. Zhongguo Zhong Yao Za Zhi. 2020. 45(9):2165-2171.
    [25] Chen YS, Zhang SM, Tan W, et al. Early 7,8-Dihydroxyflavone Administration Ameliorates Synaptic and Behavioral Deficits in the Young FXS Animal Model by Acting on BDNF-TrkB Pathway[J]. Mol Neurobiol, 2023,60(5):2539-2552.
    [26] Mashayekhi F, Hadavi M, Vaziri HR, Naji M. Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease. J Clin Neurosci. 2010. 17(3):357-9.
    [27] Peng D, Wang Y, Xiao Y, et al. Extracellular vesicles derived from astrocyte-treated with haFGF (14-154) attenuate Alzheimer phenotype in AD mice. Theranostics. 2022. 12(8):3862-3881.
    [28] Meng T, Cao Q, Lei P, et al. Tat-haFGF (14-154) Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway. Mol Ther Nucleic Acids. 2017. 7:439-452.
    [29] Chang YT, Kazui H, Ikeda M, et al. Genetic Interaction of APOE and FGF1 is Associated with Memory Impairment and Hippocampal Atrophy in Alzheimer's Disease. Aging Dis. 2019. 10(3):510-519.
    [30] Wheeler MA, Jaronen M, Covacu R, et al. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation. Cell. 2019. 176(3):581-596.e18.
    [31] Woodbury ME, Ikezu T. Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol. 2014. 9(2):92-101.
    [32] Katsouri L, Ashraf A, Birch AM, Lee KK, Mirzaei N, Sastre M. Systemic administration of fibroblast growth factor-2(FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice. Neurobiol Aging. 2015. 36(2):821-31.
    [33] Chen X, Li Z, Cheng Y, Kardami E, Loh YP. Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity. Front Mol Neurosci. 2019. 12:328.
    [34] Zhang C, Han M, Wu S. Silencing fibroblast growth factor 7 inhibits krypton laser-induced choroidal neovascularization in a rat model. J Cell Biochem. 2019. 120(8):13792-13801.
    [35] Huang T, Wang L, Liu D, et al. FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. Int J Oncol. 2017. 50(5):1501-1512.
    [36] Takaya K, Aramaki-Hattori N, Sakai S, Okabe K, Asou T, Kishi K. Fibroblast Growth Factor 7 Suppresses Fibrosis and Promotes Epithelialization during Wound Healing in Mouse Fetuses. Int J Mol Sci. 2022. 23(13).
    [37] Abubakar MB, Sanusi KO, Ugusman A, et al. Alzheimer's Disease:An Update and Insights Into Pathophysiology. Front Aging Neurosci. 2022. 14:742408.
    [38] Samadian M, Gholipour M, Hajiesmaeili M, et al. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease. Front Aging Neurosci, 2021,13:641080.
    [39] Chen W, Wu L, Hu Y, et al. MicroRNA-107 Ameliorates Damage in a Cell Model of Alzheimer's Disease by Mediating the FGF7/FGFR2/PI3K/Akt Pathway. J Mol Neurosci. 2020. 70(10):1589-1597.
    [40] Lu H, Yin M, Wang L, et al. FGF13 interaction with SHCBP1 activates AKT-GSK3α/β signaling and promotes the proliferation of A549 cells. Cancer Biol Ther. 2020. 21(11):1014-1024.
    [41] Pan X, Zhao J, Zhou Z, et al. 5'-UTR SNP of FGF13 causes translational defect and intellectual disability. Elife. 2021. 10.
    [42] Tfilin M, Turgeman G. Interleukine-17 Administration Modulates Adult Hippocampal Neurogenesis and Improves Spatial Learning in Mice. J Mol Neurosci. 2019. 69(2):254-263.
    [43] Li RM, Xiao L, Zhang T, et al. Overexpression of fibroblast growth factor 13 ameliorates amyloid-β-induced neuronal damage. Neural Regen Res, 2023,18(6):1347-1353.
    [44] Wang L, Jing R, Wang X, et al. A method for the expression of fibroblast growth factor 14 and assessment of its neuroprotective effect in an Alzheimer's disease model. Ann Transl Med. 2021. 9(12):994.
    [45] Hsu WJ, Wildburger NC, Haidacher SJ, et al. PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease. Exp Neurol. 2017. 295:1-17.
    [46] Conte M, Sabbatinelli J, Chiariello A, et al. Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging. Geroscience. 2021. 43(2):985-1001.
    [47] Kakoty V, K C S, Tang RD, Yang CH, Dubey SK, Taliyan R. Fibroblast growth factor 21 and autophagy:A complex interplay in Parkinson disease. Biomed Pharmacother. 2020. 127:110145.
    [48] Sun Y, Wang Y, Chen ST, et al. Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21. Theranostics. 2020. 10(18):8430-8445.
    [49] Chen S, Chen ST, Sun Y, et al. Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer's disease. Redox Biol. 2019. 22:101133.
    [50] Drew DA, Katz R, Kritchevsky S, et al. Fibroblast Growth Factor 23 and Blood Pressure in Older Adults:The Health, Aging, and Body Composition Study. Hypertension. 2020. 76(1):236-243.
    [51] Laszczyk AM, Nettles D, Pollock TA, et al. FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function. eNeuro. 2019. 6(2).
    [52] McGrath ER, Himali JJ, Levy D, et al. Circulating fibroblast growth factor 23 levels and incident dementia:The Framingham heart study. PLoS One. 2019. 14(3):e0213321.
    [53] Li B, Zhou M, Peng J, et al. Mechanism of the Fibroblast Growth Factor 23/α-Klotho Axis in Peripheral Blood Mononuclear Cell Inflammation in Alzheimer's Disease. Immunol Invest. 2022. 51(5):1471-1484.
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (22) PDF downloads(5) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return